DANIEL HAMSTRA to Biomarkers, Tumor
This is a "connection" page, showing publications DANIEL HAMSTRA has written about Biomarkers, Tumor.
Connection Strength
0.335
-
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202. J Clin Oncol. 2019 01 20; 37(3):213-221.
Score: 0.088
-
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer. Prostate Cancer Prostatic Dis. 2015 Sep; 18(3):229-36.
Score: 0.069
-
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer. Cancer. 2013 Feb 01; 119(3):681-90.
Score: 0.057
-
The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med. 2009 May; 15(5):572-6.
Score: 0.045
-
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol. 2008 Jul 10; 26(20):3387-94.
Score: 0.043
-
Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker. Clin Cancer Res. 2004 Dec 01; 10(23):7852-9.
Score: 0.033